A diagnosis of an H3G34-mutant glioma or HGAP would not be made on the basis of ATRX IHC even in cases where those diagnoses are suspected, and sequencing or methylation profiling would be necessary, respectively. This evidence concerns the gene ATRX and central nervous system cancer.